Neovacs proposes rights offering

Neovacs S.A. (Euronext:ALNEV), Paris, France Business: Autoimmune, Inflammation, Cancer Date announced: 2/15/13 Type: Rights offering To be raised: Up to €7.2 million ($9.6 million) Shares: 4 million ...